Free Trial

Nyxoah (NYXH) Competitors

Nyxoah logo
$7.75 -0.05 (-0.64%)
Closing price 04:00 PM Eastern
Extended Trading
$7.97 +0.22 (+2.89%)
As of 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NYXH vs. MDXG, INMD, SSII, BBNX, SIBN, IRMD, CBLL, BFLY, RXST, and AVNS

Should you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include MiMedx Group (MDXG), InMode (INMD), SS Innovations International (SSII), Beta Bionics (BBNX), SI-BONE (SIBN), Iradimed (IRMD), CeriBell (CBLL), Butterfly Network (BFLY), RxSight (RXST), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry.

Nyxoah vs. Its Competitors

MiMedx Group (NASDAQ:MDXG) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, community ranking, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

MiMedx Group has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500.

79.2% of MiMedx Group shares are held by institutional investors. 1.7% of MiMedx Group shares are held by insiders. Comparatively, 17.1% of Nyxoah shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

MiMedx Group presently has a consensus target price of $12.50, suggesting a potential upside of 94.70%. Nyxoah has a consensus target price of $14.50, suggesting a potential upside of 87.10%. Given MiMedx Group's higher possible upside, research analysts plainly believe MiMedx Group is more favorable than Nyxoah.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiMedx Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Nyxoah
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

MiMedx Group received 10 more outperform votes than Nyxoah when rated by MarketBeat users. Likewise, 83.87% of users gave MiMedx Group an outperform vote while only 73.68% of users gave Nyxoah an outperform vote.

CompanyUnderperformOutperform
MiMedx GroupOutperform Votes
52
83.87%
Underperform Votes
10
16.13%
NyxoahOutperform Votes
42
73.68%
Underperform Votes
15
26.32%

In the previous week, MiMedx Group had 2 more articles in the media than Nyxoah. MarketBeat recorded 8 mentions for MiMedx Group and 6 mentions for Nyxoah. Nyxoah's average media sentiment score of 1.54 beat MiMedx Group's score of 1.50 indicating that Nyxoah is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MiMedx Group
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Nyxoah
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

MiMedx Group has a net margin of 23.86% compared to Nyxoah's net margin of -1,043.93%. MiMedx Group's return on equity of 26.21% beat Nyxoah's return on equity.

Company Net Margins Return on Equity Return on Assets
MiMedx Group23.86% 26.21% 18.15%
Nyxoah -1,043.93%-51.68%-40.11%

MiMedx Group has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiMedx Group$352.38M2.69$58.23M$0.2723.78
Nyxoah$4.36M60.49-$46.77M-$2.13-3.64

Summary

MiMedx Group beats Nyxoah on 13 of the 17 factors compared between the two stocks.

Get Nyxoah News Delivered to You Automatically

Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NYXH vs. The Competition

MetricNyxoahSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$263.97M$4.40B$5.56B$8.61B
Dividend YieldN/A42.67%5.27%4.19%
P/E Ratio-4.1428.4427.1720.06
Price / Sales60.4971.85409.72157.10
Price / CashN/A51.0838.2534.64
Price / BookN/A5.917.064.70
Net Income-$46.77M$67.63M$3.23B$247.88M
7 Day Performance0.39%2.05%2.68%2.20%
1 Month Performance23.02%18.79%12.02%9.44%
1 Year Performance-8.50%19.13%31.24%14.72%

Nyxoah Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NYXH
Nyxoah
2.5336 of 5 stars
$7.75
-0.6%
$14.50
+87.1%
-11.2%$263.97M$4.36M-4.14110Short Interest ↑
Analyst Revision
MDXG
MiMedx Group
3.8467 of 5 stars
$6.45
-0.6%
$12.50
+93.8%
-6.6%$952.68M$352.38M11.73870Positive News
Analyst Revision
INMD
InMode
3.8874 of 5 stars
$14.56
+2.8%
$18.54
+27.3%
-21.8%$920.32M$392.41M6.20480Positive News
SSII
SS Innovations International
N/A$4.58
-23.7%
N/AN/A$886.71M$22.13M0.004Positive News
Gap Up
High Trading Volume
BBNX
Beta Bionics
N/A$19.41
+1.7%
$23.13
+19.1%
N/A$841.54M$69.83M0.00294
SIBN
SI-BONE
3.5228 of 5 stars
$18.86
-0.2%
$22.50
+19.3%
+45.2%$803.72M$176.60M-20.50350Positive News
Analyst Revision
IRMD
Iradimed
4.6474 of 5 stars
$60.80
+0.5%
$72.00
+18.4%
+41.0%$773.07M$75.15M40.53110Positive News
CBLL
CeriBell
2.4373 of 5 stars
$17.81
-0.4%
$32.50
+82.5%
N/A$643.71M$71.54M0.00N/APositive News
BFLY
Butterfly Network
2.0924 of 5 stars
$2.48
flat
$4.00
+61.3%
+175.6%$613.28M$85.63M-5.39460
RXST
RxSight
3.341 of 5 stars
$15.30
+1.7%
$37.90
+147.7%
-73.4%$611.18M$148.31M-18.43220Positive News
Gap Up
AVNS
Avanos Medical
1.7649 of 5 stars
$12.63
+1.4%
N/A-33.4%$584.06M$689.20M37.154,040

Related Companies and Tools


This page (NASDAQ:NYXH) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners